There just seems to be an "all out blitz" so to speak to showcase Avid....and I think seeing this Avid offensive play....it came not from a BP but from the FDA. Time will tell why Peregrine has been getting Avid all dolled up and ready for the dance. I hope its in response to an FDA request.
Either way....a BP will be impressed because there are not many partnerships where the small biotech has a manufacturing facility such as Peregrines Avid Bioservices.
GLTA!
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!